| Public Notice | Monitoring | N/A | N/A | Sep 6, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 6, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 2, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2025 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Jul 4, 2025 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | Jul 2, 2025 | Active | N/A |
| E. COLI | Monitoring | 0 | N/A | Jun 24, 2025 | Resolved | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Public Notice | Monitoring | N/A | N/A | May 29, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 29, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 26, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 26, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 26, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 2, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 2, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 2, 2025 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 5, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 5, 2025 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 5, 2025 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2024 | Resolved | N/A |
| E. COLI | Monitoring | 0 | N/A | Nov 15, 2024 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 15, 2024 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| E. COLI | Monitoring | 0 | N/A | Nov 15, 2024 | Active | Severe gastrointestinal illness; may be fatal in vulnerable populations |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2024 | Active | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| HEXACHLOROBENZENE | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Chlordane | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Heptachlor epoxide | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Cardiovascular system or reproductive problems |
| Atrazine | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | Cardiovascular system or reproductive problems |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Hexachlorocyclopentadiene | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Methoxychlor | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Pentachlorophenol | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Endrin | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| BHC-GAMMA | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Toxaphene | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Simazine | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) phthalate | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| LASSO | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Heptachlor | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Benzo(a)pyrene | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Di(2-ethylhexyl) adipate | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 21, 2024 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| CARBON, TOTAL | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Chlorite | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | Anemia; nervous system effects in infants and young children |
| Chlorite | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | Anemia; nervous system effects in infants and young children |
| Chlorite | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | Anemia; nervous system effects in infants and young children |
| Chlorite | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | Anemia; nervous system effects in infants and young children |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 29, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2024 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2023 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Oct 31, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Sep 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 1, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Aug 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jul 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jun 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | May 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Apr 30, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 1, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Mar 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Feb 28, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Jan 31, 2022 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Public Notice | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Nitrate | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | Infants below the age of six months could become seriously ill (blue baby syndrome); shortness of breath |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Dec 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Monitoring | N/A | N/A | Nov 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Oct 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Sep 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Aug 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 14, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 14, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 3, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jul 3, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Lead and Copper Rule | Monitoring | N/A | N/A | Jun 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | May 31, 2021 | Resolved | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 1, 2021 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 1, 2021 | Active | N/A |
| Revised Total Coliform Rule | Health-Based | N/A | N/A | May 1, 2021 | Active | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 30, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Apr 17, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Mar 31, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |
| Public Notice | Monitoring | N/A | N/A | Feb 28, 2021 | Resolved | N/A |